Candela Corporation, a leading global medical aesthetic device company, announced the publication
of the largest study of infants and babies treated with a laser for birthmarks, port wine stains, and other vascular related skin conditions on the face and body. Roy Geronemus, M.D., a world authority on the treatment of laser-based vascular anomalies at Laser & Skin Surgery Center of New York, treated a total of 197 infants and babies with the Vbeam laser in an office setting without
the need for anesthesia or surgery. The results of these Vbeam treatments include 26% of the patients experiencing complete clearing and 41% having greater than 75% improvement, with no cases of scarring or pigmentary change.
Candela recently introduced the Vbeam Prima laser system to the market, representing the latest innovation in 30 years of clinical leadership for the Vbeam franchise.